Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency
Other Reviews - Other Review
Details- 2010
- Taylor JR
Exercise programs for children with cystic fibrosis: a systematic review of randomized controlled trials
Other Reviews - Other Review
Details- 2010
- van Doorn N
Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis
Other Reviews - Other Review
Details- 2009
- Florescu DF
Ivacaftor-tezacaftor-elexacaftor, tezacaftor-ivacaftor and lumacaftor-ivacaftor for treating cystic fibrosis: a systematic review and economic evaluation.
HTA - Health Technology Assessment Report
Details- 2025
- Edwards SJ
[Cystic fibrosis carrier screening: a Health technology assessment.].
HTA - Health Technology Assessment Report
Details- 2024
- Colombo C
Lumacaftor/ivacaftor - assessment according to §35a (para. 1, sentence 10) Social Code Book V (Structured abstract)
HTA - Health Technology Assessment Report
Details- 2016
- Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Ivacaftor - assessment according to §35a (para. 1, sentence 10) Social Code Book V (Structured abstract)
HTA - Health Technology Assessment Report
Details- 2016
- Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
High-frequency chest wall compression for cystic fibrosis
HTA - Health Technology Assessment Report
Details- 2016
- HAYES
Lumacaftor-ivacaftor (Orkambi) for treatment of cystic fibrosis (Structured abstract)
HTA - Health Technology Assessment Report
Details- 2015
- HAYES
Tobramycin inhalation powder versus Tobramycin inhalation solution for cystic fibrosis (Structured abstract)
HTA - Health Technology Assessment Report
Details- 2015
- Hernández-Vásquez A